Europe BGMS (Blood Glucose Monitoring System) Market was valued at USD 2.5 Billion in 2022 and is projected to reach USD 4.5 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The European Blood Glucose Monitoring System (BGMS) market is experiencing significant growth, driven by the increasing prevalence of diabetes and advancements in monitoring technologies. As of 2023, Europe is home to approximately 60 million individuals living with diabetes, underscoring the critical need for effective glucose monitoring solutions.
Market Overview
Market Size and Growth: The European BGMS market was valued at USD 3.31 billion in 2023 and is projected to reach USD 5.41 billion by 2028, reflecting a Compound Annual Growth Rate (CAGR) of 10.37% during the forecast period.
Product Segmentation: The market is segmented into Self-Monitoring Blood Glucose (SMBG) devices and Continuous Glucose Monitoring (CGM) devices. SMBG devices include blood glucose meters, testing strips, and lancets, while CGM devices comprise sensors, transmitters, receivers, and insulin pumps.
Industry Requirements and Trends
Accuracy and Reliability: Healthcare providers demand highly accurate and reliable BGMS devices to ensure effective diabetes management and reduce the risk of complications.
Technological Integration: The integration of BGMS devices with digital health platforms and mobile applications is becoming essential. This connectivity facilitates real-time data sharing between patients and healthcare professionals, enabling timely interventions.
User-Friendly Design: Devices with intuitive interfaces and minimal maintenance requirements are preferred to enhance patient compliance and ease of use.
Regulatory Compliance: Adherence to stringent regulatory standards set by European health authorities is mandatory for market approval and acceptance.
Technological Advancements
The BGMS market is witnessing rapid technological advancements aimed at improving patient outcomes:
Continuous Glucose Monitoring (CGM): Modern CGM systems provide real-time glucose readings, trend data, and alerts for hypo- or hyperglycemia, enhancing proactive diabetes management.
Integration with Insulin Delivery Systems: The convergence of CGM devices with insulin pumps allows for automated insulin delivery, optimizing glycemic control.
Wearable Technology: The development of discreet, wearable BGMS devices offers continuous monitoring without disrupting daily activities.
Challenges and Opportunities
Despite the positive trajectory, the BGMS market faces challenges that present opportunities for innovation:
Cost Considerations: The high cost of advanced BGMS devices can be a barrier to widespread adoption. Developing cost-effective solutions without compromising quality is crucial.
Data Privacy and Security: With increased digital integration, ensuring the privacy and security of patient data is paramount to maintain trust and compliance with regulations.
Patient Education: Educating patients on the effective use of BGMS devices and the interpretation of data is essential for optimal diabetes management.
Comparative Insight: 100 Gigabit Fiber Optic Transceiver Market
Drawing a parallel to the 100 Gigabit Fiber Optic Transceiver market, which is projected to reach USD 4.56 billion by 2030 with a CAGR of 11.8%, we observe a similar emphasis on technological advancement and integration to meet industry demands. Both markets highlight the importance of accuracy, reliability, and user-centric design in driving adoption and growth.
Conclusion
The European BGMS market is poised for substantial growth, driven by rising diabetes prevalence and technological innovations. By addressing industry requirements and challenges, manufacturers and healthcare providers can enhance diabetes management and improve patient quality of life.
Get an In-Depth Research Analysis of the Europe BGMS (Blood Glucose Monitoring System) Market Size And Forecast [2025-2032]
Â
Roche
Lifescan
Abbott
All Medicus
Terumo
Ascensia (Bayer)
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe BGMS (Blood Glucose Monitoring System) Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe BGMS (Blood Glucose Monitoring System) Market
Self-Monitoring Blood Glucose (SMBG) Devices
Continuous Glucose Monitoring (CGM) Devices
Glucometers
Test Strips and Sensors
Handheld Devices
Smart Glucose Meters
Electrochemical Technology
Optical Technology
Non-Invasive Technology
Wearable Technology
Online Pharmacies
Retail Pharmacies
Hospitals and Clinics
Direct Sales
E-commerce Platforms
Homecare Settings
Hospitals
Diabetes Care Centers
Research and Clinical Laboratories
Nursing Homes
Type 1 Diabetes Management
Type 2 Diabetes Management
Gestational Diabetes Management
Diabetes Research
Patients with Hypoglycemia
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ BGMS (Blood Glucose Monitoring System) Market Research Analysis
1. Introduction of the Europe BGMS (Blood Glucose Monitoring System) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe BGMS (Blood Glucose Monitoring System) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe BGMS (Blood Glucose Monitoring System) Market, By Type
6. Europe BGMS (Blood Glucose Monitoring System) Market, By Application
7. Europe BGMS (Blood Glucose Monitoring System) Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe BGMS (Blood Glucose Monitoring System) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/